These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 6998487

  • 1. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D, Bonelli J, Hitzenberger G, Kaik G.
    Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
    [Abstract] [Full Text] [Related]

  • 2. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL, Strocchi E, Ambrosioni E, Magnani B.
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine.
    Kirch W, Distler A.
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):132-5. PubMed ID: 348614
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG, Bloxham CA, Walker JM.
    Pharmatherapeutica; 1981 Mar; 2(8):513-6. PubMed ID: 7019931
    [Abstract] [Full Text] [Related]

  • 8. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N, Knaup G.
    Med Welt; 1983 Feb 04; 34(5):158-61. PubMed ID: 6341756
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term clinical experience with guanfacine.
    Fetkovská N, Brimichová G, Sebeková K, Dzúrik R.
    Cor Vasa; 1987 Feb 04; 29(4 Suppl 1):23-9. PubMed ID: 3315447
    [Abstract] [Full Text] [Related]

  • 13. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F, Widler J.
    Schweiz Med Wochenschr; 1981 Dec 12; 111(50):1967-8. PubMed ID: 7036334
    [Abstract] [Full Text] [Related]

  • 14. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J, Schäfer N, Rauh J, Raschig A.
    Dtsch Med Wochenschr; 1980 Nov 28; 105(48):1680-4. PubMed ID: 7002524
    [Abstract] [Full Text] [Related]

  • 15. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O, Valenzuela MA, Salazar R.
    Rev Med Chil; 1982 Dec 28; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract] [Full Text] [Related]

  • 16. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun 28; 19(6):279-87. PubMed ID: 7030975
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 28; 22(3):170-4. PubMed ID: 6370876
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.